Synthesis of 2D MOFs is often sensitive to the reaction conditions like temperature and solvent etc. Cu(II)-5-azidoisophthalate MOF (Cu(II)–5N₃IP) has been synthesized at room temperature as well as under solvothermal conditions. The azide functional group remained stable during solvothermal synthesis at 85 °C. Cu(II)–5N₃IP crystallized in a Kagomé-type structure. Typical Cu₂ paddle-wheels are connected to each other by 5N₃IP ligands in infinite 2D sheets in the (001) plane, featuring 1D infinite channels within each layer. This MOF is used for the adsorption of methylene blue (MB), rhodamine B (RhB), methyl orange (MO), and Congo red (CR). The adsorption is selective to the dimensions, shapes and ionic strengths of the dyes. Cu(II)–5N₃IP exhibited adsorption rates in the order MB > CR > RhB > MO. Cu(II)–5N₃IP is used as a catalyst for aerobic oxidation and Knoevenagel condensation. 3–10 mol% of Cu–5N₃IP selectively catalyzes the oxidation of benzyl alcohol to benzaldehyde in 9–20 h at 60 °C. In Knoevenagel condensation, the reaction of both unsubstituted and substituted benzaldehydes at room temperature was observed at a very low catalyst loading of 3 mol% of MOF within a short time of 3–60 min. This 2D MOF has proved to be more efficient for dye adsorption and the catalytic applications under investigation (such as alcohol oxidation and Knoevenagel condensation) than its analogous 3D or 0D materials.

Dinuclear Co-based catalysts are used for the coupling reaction of epoxides and CO₂ in the presence of a cocatalyst.

Chemical insertion of carbon dioxide into epoxides under ambient conditions has become one of the most important methods for the construction of cyclic organic carbonates. Various active salen, salophen, and phenolate ligand based complexes have been reported for the synthesis of cyclic organic carbonates. Here we demonstrate a series of ONO pincer type cobalt (III) complexes as efficient catalysts for the cycloaddition of carbon dioxide to epoxides in neat conditions at atmospheric pressure with and without co-catalyst. A turnover number of up to 200,000 under atmospheric pressure is achieved. Moreover, the in situ generated complex shows high activity and the catalyst can be reused for at least 11 cycles without any decline in catalytic performance.

A new series of 1,3,4-oxadiazoles derivatives was synthesized, characterized, and evaluated for their in vitro and in vivo anti-thrombotic activity. Compounds (3a–3i) exhibited significant clot lysis with respect to reference drug streptokinase (30,000 IU), and enhanced clotting time (CT) values (130–342 s) than heparin (110 s). High affinity towards 1NFY with greater docking score was observed for the compounds (3a, 3i, 3e, 3d, and 3h) than the control ligand RPR200095. In addition, impressive inhibitory potential against factor Xa (F-Xa) was observed with higher docking scores (5612–6270) with Atomic Contact Energy (ACE) values (−189.68 to −352.28 kcal/mol) than the control ligand RPR200095 (Docking score 5192; ACE −197.81 kcal/mol). In vitro, in vivo, and in silico results proposed that these newly synthesized compounds might be used as anticoagulant agents.